Neuros Biotechnology
Sunderland
About Neuros Biotechnology
Neuros Biotechnology, pioneering a groundbreaking approach to combating Alzheimer's disease (AD) through innovative neurogenic therapies, aims to treat AD holistically, addressing every aspect of lifestyle-related disease modification, combined with harnessing the potent capabilities of NB-Px, a human-derived mixed biologic with unique neuro-regenerative properties.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $25.0K
- Funding stage: Seed
- Last round: Pre-Seed (Apr 2025)
- Website: neurosbio.com
- Phone: (408) 348-5056
Industries & Categories
Biopharma, Biotechnology, Neuroscience, Therapeutics
Canonical: https://fsome.com/organization/neuros-biotechnology-147872 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.